CAD ACS & AMI

Workshop

APPLYING THE 2019 CCS STEMI GUIDELINES TO CHALLENGING STEMI CASES

Co-Chair(s)

• 

  Warren Cantor, MD, FRCPC, FSCAI, FCCS

  Director, Interventional Cardiology Research
  Southlake Regional Health Centre
  University of Toronto
• 

  Graham Wong, MD MPH

  Clinical Professor and Program Director, UBC Cardiology Training Program
  UBC
  CANCARE

Presenter(s)

• 

  Richard Vandegriend

  Cardiologist and Cardiac Intensivist
  Royal Columbian Hospital Fraser Health
  University of British Columbia
• Joseph M.

  Joseph Minkowitz, MDCM FRCPC FCCS

  Lead Cardiologist
  Markham Stouffville Hospital
• 

  Michele Perry Arnesen, MHA, BSN, RN

  Manager Clinical Operations, Cardiac Services and ICU
  Fraser Health Authority
• 

  Laurie Lambert, MPH, PhD

  Principal scientist
  Institut national d'excellence en santéet en services sociaux (INESSS)
• 

  Andrea Lavoie, MD FRCPC

  Assistant Professor
  University of Saskatchewan
  University of Saskatchewan
• Matthew S.

  Matthew Sibbald

  Cardiologist

Planning Committee Member(s)

• Matthew S.

  Matthew Sibbald

  Cardiologist
• Erin R.

  Erin Rayner-Hartley, MD

  Critical Care Medicine Fellow, Cleveland Clinic
• 

  Sean Van Diepen, MS MSc

  Associate Professor
  University of Alberta
  University of Alberta
• 

  Jacqueline Saw

  MD
  University of British Columbia

We are proposing a highly interactive case based workshop to highlight the CCS-CAIC STEMI guidelines which were presented at the CCC in October, 2019 and published in the Canadian Journal of Cardiology in Feb 2019. Two STEMI clinical case scenarios will be presented, one involving a patient who presents to a non-PCI centre and another for a patient who is identified by paramedics in the field. One of the cases will also involve cardiac arrest. Each case will be presented (5 min) followed by an interactive session with the audience using the IVRS; the audience will then be asked to vote on next steps for key decision points outlined in each case (15 minutes); audience members will also be offered the opportunity to use the microphone to discuss their responses and their rationale. The panel will then have 5 minutes to discuss the guideline recommendation for that scenario, the evidence that supports the recommendation and comment on any issues that are unknow or remain controversial. Thus each case segment will be 25 minutes, with >50% of each case dedicated to interactive audience participation. 5 minutes will be reserved for introduction and 5 minutes will be reserved for a wrapup discussion.

Element Speaker/Discussant Time Alloted (min)
Introduction Co-chairs 5
Case 1 (Non PCI Centre pt) E. Rayner-Hartley 5
Case Discussion Audience (IVRS and microphone) 15
Panel Discussion Panelists 5
Case 1 (Non PCI Centre pt) M. Perry-Arnesen 5
Case Discussion Audience (IVRS and microphone) 15
Panel Discussion Panelists 5
Wrapup Co-chairs 5

TOTAL TIME 60

 

Learning Objectives

At the conclusion of this session, participants will be able to:

• select the best reperfusion therapy (primary PCI vs. fibrinolysis) for STEMI patients based on timing, setting and patient characteristics;
• determine the most appropriate methods of transporting STEMI patients, and the role of adjunct therapy (including oxygen, opiates and antiplatelet therapy) in the ambulance; and
• optimize their regional STEMI networks to enable rapid diagnosis and treatment of STEMI, and to provide routine early PCI after fibrinolysis.